参考文献
［1］Luke J J，Flaherty K T，Ribas A，et al.Targeted agents and immunotherapies：optimizing outcomes in melanoma［J］.Nat Rev Clin Oncol，2017，14（8）：463-482.
［2］Zhang Z，Tongchusak S，Mizukami Y，et al.Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery［J］.Biomaterials，2011，32（14）：3666-3678.
［3］Rosalia R A，Cruz L J，van Duikeren S，et al.CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses［J］.Biomaterials，2015，40：88-97.
［4］Solbrig C M，Saucier-Sawyer J K，Cody V，et al.Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells［J］.Mol Pharm，2007，4（1）：47-57.
［5］Min Y，Roche K C，Tian S，et al.Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy［J］.Nat Nanotechnol，2017，12（9）：877-882.
［6］Molavi O，Mahmud A，Hamdy S，et al.Development of a poly（D，L-lactic-co-glycolic acid）nanoparticle formulation of STAT3 inhibitor JSI-124：implication for cancer immunotherapy［J］.Mol Pharm，2010，7（2）：364-374.
［7］Roy A，Singh M S，Upadhyay P，et al.Combined chemo-immunotherapy as a prospective strategy to combat cancer：a nanoparticle based approach［J］.Mol Pharm，2010，7（5）：1778-1788.
［8］Kim H，Niu L，Larson P，et al.Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy［J］.Biomaterials，2018，164：38-53.
［9］Mi Y，Smith C C，Yang F，et al.A dual immunotherapy nanoparticle improves T-cell activation and cancer immunotherapy［J］.Adv Mater，2018，30（25）：e1706098.
［10］Schmid D，Park C G，Hartl C A，et al.T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity［J］.Nat Commun，2017，8（1）：1747.
［11］Shi C，Liu T，Guo Z，et al.Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration［J］.Nano Lett，2018，18（11）：7330-7342.
［12］Luo L，Yang J，Zhu C，et al.Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors［J］.J Control Release，2018，278：87-99.
［13］Ou W，Jiang L，Thapa R K，et al.Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy［J］.Theranostics，2018，8（17）：4574-4590.
［14］Napoli A，Valentini M，Tirelli N，et al.Oxidation-responsive polymeric vesicles［J］.Nat Mater，2004，3（3）：183-189.
［15］Thomas S N，Vokali E，Lund A W，et al.Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response［J］.Biomaterials，2014，35（2）：814-824.
［16］Silva J M，Zupancic E，Vandermeulen G，et al.In vivo delivery of peptides and toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model［J］.J Control Release，2015，198：91-103.
［17］Rodell C B，Arlauckas S P，Cuccarese M F，et al.TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy［J］.Nat Biomed Eng，2018，2（8）：578-588.
［18］Umeki Y，Mohri K，Kawasaki Y，et al.Induction of potent antitumor immunity by sustained release of cationic antigen from a DNA-based hydrogel with adjuvant activity［J］.Adv Funct Mater，2015，25（36）：5758-5767.
［19］Wang C，Li P，Liu L，et al.Self-adjuvanted nanovaccine for cancer immunotherapy：role of lysosomal rupture-induced ROS in MHC class Ⅰ antigen presentation［J］.Biomaterials，2016，79：88-100.
［20］Fan Y，Kuai R，Xu Y，et al.Immunogenic cell death amplified by co-localized adjuvant delivery for cancer immunotherapy［J］.Nano Lett，2017，17（12）：7387-7393.
［21］Gao M，Zhu X，Wu L，et al.Cationic polyphosphazene vesicles for cancer immunotherapy by efficient in vivo cytokine IL-12 plasmid delivery［J］.Biomacromolecules，2016，17（6）：2199-2209.
［22］Smith T T，Stephan S B，Moffett H F，et al.In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers［J］.Nat Nanotechnol，2017，12（8）：813-820.
［23］Shae D，Becker K W，Christov P，et al.Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy［J］.Nat Nanotechnol，2019，14（3）：269-278.
［24］Tsai S J，Andorko J I，Zeng X，et al.Polyplex interaction strength as a driver of potency during cancer immunotherapy［J］.Nano Res，2018，11（10）：5642-5656.
［25］Wang C，Sun W，Wright G，et al.Inflammation-triggered cancer immunotherapy by programmed delivery of CpG and anti-PD1 antibody［J］.Adv Mater，2016，28（40）：8912-8920.
［26］Kuai R，Ochyl L J，Bahjat K S，et al.Designer vaccine nanodiscs for personalized cancer immunotherapy［J］.Nat Mater，2017，16（4）：489-496.
［27］Chen Y，Xia R，Huang Y，et al.An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy［J］.Nat Commun，2016，7：13443.(https://www.daowen.com)
［28］Wang D，Wang T，Liu J，et al.Acid-activatable versatile micelleplexes for PD-L1 blockade-enhanced cancer photodynamic immunotherapy［J］.Nano Lett，2016，16（9）：5503-5513.
［29］Luo M，Wang H，Wang Z，et al.A STING-activating nanovaccine for cancer immunotherapy［J］.Nat Nanotechnol，2017，12（7）：648-654.
［30］Luo Z，Li P，Deng J，et al.Cationic polypeptide micelle-based antigen delivery system：a simple and robust adjuvant to improve vaccine efficacy［J］.J Control Release，2013，170（2）：259-267.
［31］De Temmerman M L，Rejman J，Vandenbroucke R E，et al.Polyelectrolyte LBL microcapsules versus PLGA microparticles for immunization with a protein antigen［J］.J Control Release，2012，158（2）：233-239.
［32］Devy J，Balasse E，Kaplan H，et al.Hydroxyethylstarch microcapsules：a preliminary study for tumor immunotherapy application［J］.Int J Pharm，2006，307（2）：194-200.
［33］Xia Y，Wu J，Wei W，et al.Exploiting the pliability and lateral mobility of pickering emulsion for enhanced vaccination［J］.Nat Mater，2018，17（2）：187-194.
［34］Kosmides A K，Meyer R A，Hickey J W，et al.Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma［J］.Biomaterials，2017，118：16-26.
［35］Bencherif S A，Warren Sands R，Ali O A，et al.Injectable cryogel-based whole-cell cancer vaccines［J］.Nat Commun，2015，6：7556.
［36］Liu Y，Xiao L，Joo K I，et al.In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice［J］.Biomacromolecules，2014，15（10）：3836-3845.
［37］Song H，Huang P，Niu J，et al.Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma［J］.Biomaterials，2018，159：119-129.
［38］Ruan H，Hu Q，Wen D，et al.A dual-bioresponsive drug-delivery depot for combination of epigenetic modulation and immune checkpoint blockade［J］.Adv Mater，2019，31（17）：e1806957.
［39］Yu S，Wang C，Yu J，et al.Injectable bioresponsive gel depot for enhanced immune checkpoint blockade［J］.Adv Mater，2018，30（28）：e1801527.
［40］Chen Q，Wang C，Zhang X，et al.In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment［J］.Nat Nanotechnol，2019，14（1）：89-97.
［41］Duong H T T，Thambi T，Yin Y，et al.Degradation-regulated architecture of injectable smart hydrogels enhances humoral immune response and potentiates antitumor activity in human lung carcinoma［J］.Biomaterials，2020，230：119599.
［42］Jin H，Wan C，Zou Z，et al.Tumor ablation and therapeutic immunity induction by an injectable peptide hydrogel［J］.ACS Nano，2018，12（4）：3295-3310.
［43］Dong X，Liang J，Yang A，et al.Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy［J］.Biomaterials，2019，209：111-125.
［44］Wang C，Ye Y，Hochu G M，et al.Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody［J］.Nano Lett，2016，16（4）：2334-2340.
［45］Zaric M，Lyubomska O，Touzelet O，et al.Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D，L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses［J］.ACS Nano，2013，7（3）：2042-2055.
［46］Ye Y，Wang J，Hu Q，et al.Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors［J］.ACS Nano，2016，10（9）：8956-8963.
［47］Ye Y，Wang C，Zhang X，et al.A melanin-mediated cancer immunotherapy patch［J］.Sci Immunol，2017，2（17）：eaan5692.
［48］Kim H，Seong K Y，Lee J H，et al.Biodegradable microneedle patch delivering antigenic peptide-hyaluronate conjugate for cancer immunotherapy［J］.ACS Biomater Sci Eng，2019，5（10）：5150-5158.
［49］Zeng Q，Gammon J M，Tostanoski L H，et al.In vivo expansion of melanoma-specific T cells using microneedle arrays coated with immune-polyelectrolyte multilayers［J］.ACS Biomater Sci Eng，2017，3（2）：195-205.
［50］Duong H T T，Yin Y，Thambi T，et al.Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy［J］.Biomaterials，2018，185：13-24.
［51］Duong H T T，Yin Y，Thambi T，et al.Highly potent intradermal vaccination by an array of dissolving microneedle polypeptide cocktails for cancer immunotherapy［J］.J Mater Chem B，2020，8（6）：1171-1181.
［52］Yang P，Lu C，Qin W，et al.Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy［J］.Acta Biomater，2020，104：147-157.
（刘倩倩 谢君 刘奕静）